Atıf İçin Kopyala
Ozkal-Baydin P., Gumus-Akay G., Varol N., Rustemoglu A., Koroglu R., Yuksel S., ...Daha Fazla
NUCLEAR MEDICINE COMMUNICATIONS, cilt.33, sa.4, ss.415-421, 2012 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
33
Sayı:
4
-
Basım Tarihi:
2012
-
Doi Numarası:
10.1097/mnm.0b013e3283505188
-
Dergi Adı:
NUCLEAR MEDICINE COMMUNICATIONS
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.415-421
-
Anahtar Kelimeler:
fluorescence in-situ hybridization, genotoxic effect, human lymphocyte, micronucleus, Re-186-1,1-hydroxyethylidenediphosphonate, SITU HYBRIDIZATION, PERIPHERAL-BLOOD, PROSTATE-CANCER, BONE METASTASES, ANIMAL-MODEL, ASSAY, THERAPY, DAMAGE, DNA, RADIOSYNOVIORTHESIS
-
Gazi Üniversitesi Adresli:
Evet
Özet
Aim Systemic and local therapies can be used to treat painful bone metastases. It has been shown that certain pharmaceuticals such as Re-186 (rhenium-186) are effective in the treatment of pains caused by bone metastasis and a correlation between bone metastases and T cells has also been shown. The aim of this study was to investigate the genotoxic effect of Re-186-1,1-hydroxyethylidenediphosphonate (Re-186-HEDP) on the cultured peripheral blood lymphocytes using an micronucleus (MN)-fluorescence in-situ hybridization assay.